Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men

Clinical trial NCT02443090 · UNKNOWN

Trial details

NCT number: NCT02443090
Sponsor: NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Secondary Hypogonadism Sexual Dysfunction Erectile Dysfunction

Start date: 2015-05-01
Primary completion: 2015-10-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.